In the BioHarmony Drug Report Database
Sulindac
Clinoril (sulindac) is a small molecule pharmaceutical. Sulindac was first approved as Clinoril on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, gouty arthritis, inflammation, and osteoarthritis amongst others in the USA. It is known to target prostaglandin G/H synthase 2, retinoic acid receptor RXR-alpha, and prostaglandin G/H synthase 1.
Trade Name
|
Clinoril |
|---|---|
Common Name
|
sulindac |
ChEMBL ID
|
CHEMBL15770 |
Indication
|
ankylosing spondylitis, bursitis, gouty arthritis, inflammation, osteoarthritis, rheumatoid arthritis, shoulder pain, tendinopathy |
Drug Class
|
Anti-inflammatory agents (acetic acid derivatives) |
Image (chem structure or protein)